{
  "trial_id": "NCT02190695",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "AML, relapsed or refractory to standard therapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age 65 or over with AML",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Unfit for conventional chemotherapy and AML",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "De novo or treated MDS or CMML INT-1 or above",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Prior exposure to azacitidine but no more than one cycle of decitabine",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Off chemotherapy for 2 weeks prior to entering this study and have recovered from the toxicities of that therapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Hydroxyurea is permitted for control of elevated WBC prior to treatment and can be continued for the first 4 weeks of therapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "ESAs, GCSF or other growth factors are permitted on therapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Performance 0-2 (ECOG)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Adequate cardiac functions assessed by 2D ECHO (NYHA cardiac III-IV excluded)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Pre-treatment EKG",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Adequate end organ function with creatinine </= 2mg/dL and total bilirubin </= 2mg/dL, AST and ALT </= or = 2.5 X institutional ULN",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Nursing and pregnant females",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Current uncontrolled infections",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Uncontrolled intercurrent illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, or psychiatric illness/social situations that would limit compliance with study requirements",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Chronic kidney disease > stage 3",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "HIV infection",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "A 54-year-old woman with abnormal cervical squamous intraepithelial/glandular lesion, HPV 16 positive, and a history of smoking and alcohol use. She is menopausal and uses no contraception.",
  "_meta": {
    "topic_id": "67",
    "trial_id": "NCT02190695",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}